Literature DB >> 18400862

Small intestine CD4+ T cells are profoundly depleted during acute simian-human immunodeficiency virus infection, regardless of viral pathogenicity.

Yoshinori Fukazawa1, Ariko Miyake, Kentaro Ibuki, Katsuhisa Inaba, Naoki Saito, Makiko Motohara, Reii Horiuchi, Ai Himeno, Kenta Matsuda, Megumi Matsuyama, Hidemi Takahashi, Masanori Hayami, Tatsuhiko Igarashi, Tomoyuki Miura.   

Abstract

To analyze the relationship between acute virus-induced injury and the subsequent disease phenotype, we compared the virus replication and CD4(+) T-cell profiles for monkeys infected with isogenic highly pathogenic (KS661) and moderately pathogenic (#64) simian-human immunodeficiency viruses (SHIVs). Intrarectal infusion of SHIV-KS661 resulted in rapid, systemic, and massive virus replication, while SHIV-#64 replicated more slowly and reached lower titers. Whereas KS661 systemically depleted CD4(+) T cells, #64 caused significant CD4(+) T-cell depletion only in the small intestine. We conclude that SHIV, regardless of pathogenicity, can cause injury to the small intestine and leads to CD4(+) T-cell depletion in infected animals during acute infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400862      PMCID: PMC2395167          DOI: 10.1128/JVI.02753-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques.

Authors:  S V Joag; Z Li; L Foresman; E B Stephens; L J Zhao; I Adany; D M Pinson; H M McClure; O Narayan
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus.

Authors:  T Igarashi; Y Endo; G Englund; R Sadjadpour; T Matano; C Buckler; A Buckler-White; R Plishka; T Theodore; R Shibata; M Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous.

Authors:  Tatsuhiko Igarashi; Charles R Brown; Russell A Byrum; Yoshiaki Nishimura; Yasuyuki Endo; Ronald J Plishka; Charles Buckler; Alicia Buckler-White; Georgina Miller; Vanessa M Hirsch; Malcolm A Martin
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.

Authors:  Moraima Guadalupe; Elizabeth Reay; Sumathi Sankaran; Thomas Prindiville; Jason Flamm; Andrew McNeil; Satya Dandekar
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  The quantity and diversity of infectious viruses in various tissues of SHIV-infected monkeys at the early and AIDS stages.

Authors:  A Miyake; Y Enose; S Ohkura; H Suzuki; T Kuwata; T Shimada; S Kato; O Narayan; M Hayami
Journal:  Arch Virol       Date:  2003-12-23       Impact factor: 2.574

6.  Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host.

Authors:  Jeffrey M Milush; Jacqueline D Reeves; Shari N Gordon; Dejiang Zhou; Alagar Muthukumar; David A Kosub; Elizabeth Chacko; Luis D Giavedoni; Chris C Ibegbu; Kelly S Cole; John L Miamidian; Mirko Paiardini; Ashley P Barry; Silvija I Staprans; Guido Silvestri; Donald L Sodora
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

7.  A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

Authors:  K A Reimann; J T Li; R Veazey; M Halloran; I W Park; G B Karlsson; J Sodroski; N L Letvin
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.

Authors:  Saurabh Mehandru; Michael A Poles; Klara Tenner-Racz; Amir Horowitz; Arlene Hurley; Christine Hogan; Daniel Boden; Paul Racz; Martin Markowitz
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

9.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

10.  Getting to the guts of HIV pathogenesis.

Authors:  Ronald S Veazey; Andrew A Lackner
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

View more
  3 in total

1.  Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.

Authors:  Shari N Gordon; Barbara Cervasi; Pamela Odorizzi; Randee Silverman; Faten Aberra; Gregory Ginsberg; Jacob D Estes; Mirko Paiardini; Ian Frank; Guido Silvestri
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

2.  Small intestine CD4+ cell reduction and enteropathy in simian/human immunodeficiency virus KS661-infected rhesus macaques in the presence of low viral load.

Authors:  Katsuhisa Inaba; Yoshinori Fukazawa; Kenta Matsuda; Ai Himeno; Megumi Matsuyama; Kentaro Ibuki; Yoshiharu Miura; Yoshio Koyanagi; Atsushi Nakajima; Richard S Blumberg; Hidemi Takahashi; Masanori Hayami; Tatsuhiko Igarashi; Tomoyuki Miura
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

3.  Genetic similarity of circulating and small intestinal virus at the end stage of acute pathogenic simian-human immunodeficiency virus infection.

Authors:  Megumi Matsuyama-Murata; Katsuhisa Inaba; Reii Horiuchi; Yoshinori Fukazawa; Kentaro Ibuki; Masanori Hayami; Tomoyuki Miura
Journal:  Front Microbiol       Date:  2013-07-22       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.